GaryM.FelkerMD

Cardiology • Durham, NC

Adult Congenital Heart Disease, Heart Failure & Transplantation

Associate Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Felker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Felker's full profile

Already have an account?

Office
2100 Erwin Rd
Durham, NC 27705
Phone+1 919-684-8111

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1999 - 2002
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1998 - 1999
Johns Hopkins UniversityResidency, Internal Medicine, 1993 - 1996
Duke University School of MedicineClass of 1993

Certifications & Licensure

NC State Medical License 1999 - 2025
MD State Medical License 1996 - 2000
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Mobile Health Behavioral Intervention in Patients With Heart Failure and Diabetes Mellitus Start of enrollment: 2017 Aug 02
Completed
Not Applicable

Publications & Presentations

PubMed

129 citations
Clinical Implications of the New York Heart Association Classification.
Cesar Caraballo, Nihar R. Desai, Hillary Mulder, Brooke Alhanti, F. Perry Wilson
Journal of the American Heart Association. 2019-12-03
413 citations
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Kenneth B. Margulies, Adrian F. Hernandez, Margaret M. Redfield, Michael M. Givertz, Guilherme H. Oliveira
JAMA. 2016-08-02
320 citations
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb s...
John R. Teerlink, Marco Metra, G. Michael Felker, Piotr Ponikowski, Adriaan A. Voors
Lancet. 2009-04-25

Journal Articles

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): A Phase 2, Pharmacokinetic, Randomised, Placebo-Controlled Trial
G. Michael Felker, John R. Teerlink, The Lancet